fig3
Figure 3. Extrahepatic manifestations of MASLD. Created in BioRender. Ramírez, M. (2026) https://BioRender.com/ce9bge2. MASLD: Metabolic dysfunction-associated steatotic liver disease; CKD: chronic kidney disease; CVD: cardiovascular disease; MACE: major adverse cardiovascular events; T2D: type 2 diabetes; CRC: colorectal cancer; MAFLD: metabolic-associated fatty liver disease; HCC: hepatocellular carcinoma; PCOS: polycystic ovary syndrome; SS: simple steatosis; IR: insulin resistance.
